Pluri Inc
:PSTI 3:54:37 PM EDT
Products
Pluristem Enters Collaboration With Innovare R&D To Expand COVID-19 Program To Mexico
Published: 12/29/2020 12:08 GMT
(PSTI) - Pluristem Enters Collaboration With Pharmaceutical Company Innovare Research and Development to Expand Pluristem’s Ards Associated With Covid-19 Program to Mexico.
Pluristem Therapeutics - Innovare Will Open Clinical Sites and Enroll Patients for Proposed Clinical Study in Mexico.
Pluristem Therapeutics Inc - Innovare Will Fund Study in Mexico and Will Purchase Plx Cells for Study From Pluristem.
Pluristem -agreement Grants Innovare Exclusive Distribution Rights in Mexico to Supply Plx Cells for Treating Severe Covid-19 Cases Complicated by Ards.
Pluristem Therapeutics Inc - All Intellectual Property and Manufacturing Rights Remain With Pluristem.
Pluristem Therapeutics - Innovare Will Open Clinical Sites and Enroll Patients for Proposed Clinical Study in Mexico.
Pluristem Therapeutics Inc - Innovare Will Fund Study in Mexico and Will Purchase Plx Cells for Study From Pluristem.
Pluristem -agreement Grants Innovare Exclusive Distribution Rights in Mexico to Supply Plx Cells for Treating Severe Covid-19 Cases Complicated by Ards.
Pluristem Therapeutics Inc - All Intellectual Property and Manufacturing Rights Remain With Pluristem.